Qingqing (Cheryl) Cao, PH.D. & MBA Head of Portfolio & Program Management (Director), Quanterix, Billerica, MA
Dr. Cao is an established and influential leader with extensive experience in new product development and business strategy in the biotech and medical device industry, particularly in the area of Precision/digital biomarker detection, molecular diagnostics, drug delivery and diabetes care.
With the solid technical background and great business acumen, Dr Cao is leading the strategic portfolio management and program management at Quanterix. Before joining in Quanterix, she has held multiple positions with increasing responsibility in Becton Dickinson & company (BD) and Insulet.
Dr. Cao received her Ph.D. and a M.S in Mechanical Engineering from Boston University, and got her MBA from Worcester polytechnic Institute (WPI). She co-authored 15+ peer-reviewed research publications in the leading biomedical journals. Dr. Cao have served as the General Manager in Chinese American BioMedical Association (CABA) since 2012.